PCSK9通过诱导血管平滑肌细胞表型转换促进动脉粥样硬化OA
PCSK9 promotes atherosclerosis by inducing phenotypic transformation of vascular smooth muscle cells
[目的]探讨前蛋白转化酶枯草溶菌素9(PCSK9)在动脉粥样硬化(As)发生发展中的作用及分子机制.[方法]采用血小板源性生长因子-BB(PDGF-BB)对小鼠原代血管平滑肌细胞(VSMC)进行不同时间的处理,通过划痕实验评估细胞迁移能力,并利用 Western blot 检测表型转换标志物及 PCSK9 的表达.使用 Ad-PCSK9腺病毒感染小鼠原代 VSMC,检测收缩型与合成型标志蛋白的表达情况,以及细胞增殖与迁移能力.通过腺病毒过表达或小干扰 RNA(siRNA)抑制 PCSK9 表达,检测核因子 κB(NF-κB)、Krüppel 样因子 4(KLF4)和心肌素(MYOCD)的表达水平.采用免疫组织化学、免疫荧光、油红 O 染色和苏木精-伊红(HE)染色,分析 VSMC 特异性过表达PCSK9(PCSK 9sm OE)小鼠与对照组(PCSK9flox/flox)小鼠主动脉斑块中相关分子的表达、脂质沉积及斑块面积.[结果]PCSK9 与血管中膜及 As 斑块内的 VSMC 共定位;与中膜收缩型 VSMC 相比,其在斑块合成型 VSMC 中表达显著升高.PDGF-BB 以时间依赖方式上调 PCSK9 及合成表型标志蛋白骨桥蛋白(OPN)、表皮调节素(EREG)表达,下调收缩表型标志蛋白平滑肌肌球蛋白重链(SMMHC)、α-平滑肌肌动蛋白(α-SMA)、钙调理蛋白、平滑肌 22α(SM22α)表达,并增强细胞迁移能力.Ad-PCSK9 可促进 VSMC 由收缩表型向合成表型转换,显著增强 DNA 复制活性与细胞迁移能力,同时,下调 MYOCD 表达,上调KLF4 与NF-κB p65 表达;而siRNA 抑制PCSK9 则呈现相反效应.组织学分析表明,VSMC 过表达 PCSK9 可促进 As 小鼠主动脉斑块形成并增加斑块不稳定性.[结论]PCSK9 可诱导 VSMC 由收缩表型向合成表型转换,加剧小鼠 As 病变,该机制可能与 NF-κB、KLF4 及 MYOCD 之间的信号串扰有关.
Aim To investigate the role and molecular mechanism of proprotein convertase subtilisin/kexin type 9(PCSK9)in the occurrence and development of atherosclerosis(As).Methods Mouse primary vascular smooth muscle cells(VSMCs)were treated with platelet-derived growth factor-BB(PDGF-BB)for different durations.Cell mi-gration ability was evaluated by scratch assay,and the expression of phenotypic transition markers and PCSK9 was detected by Western blot.Mouse primary VSMCs were infected with Ad-PCSK9 adenovirus to examine the expression of contractile and synthetic marker proteins,as well as cell proliferation and migration capabilities.PCSK9 expression was overex-pressed via adenovirus or inhibited by small interfering RNA(siRNA),and the expression levels of nuclear factor-κB(NF-κB),Krüppel-like factor 4(KLF4),and myocardin(MYOCD)were detected.Immunohistochemistry,immunoflu-orescence,Oil Red O staining,and hematoxylin-eosin(HE)staining were used to analyze the expression of related mole-cules,lipid deposition,and plaque area in aortic plaques of VSMC-specific PCSK9 overexpression(PCSK9sm OE)mice and PCSK9 conditional knockout(PCSK9flox/flox)mice.Results PCSK9 was colocalized with VSMCs in the medial layer and atherosclerotic plaques.Compared with contractile VSMCs in the medial layer,PCSK9 expression was significantly elevated in synthetic VSMCs within the plaques.PDGF-BB upregulated PCSK9 in a time-dependent manner,along with the synthetic phenotypic marker proteins osteopontin(OPN)and epiregulin(EREG),while downregulating the contractile marker proteins smooth muscle myosin heavy chain(SMMHC),α-smooth muscle actin(α-SMA),calponin,and smooth muscle 22α(SM22α),and enhanced cell migration capacity.Ad-PCSK9 promoted the phenotypic transformation of VSMCs from contractile to synthetic phenotype,significantly enhanced DNA replication activity and cell migration ability,downregulated MYOCD expression,and upregulated KLF4 and NF-κB p65 expression.Conversely,siRNA-mediated PC-SK9 inhibition showed opposite effects.Histological analysis revealed that VSMC-specific overexpression of PCSK9 pro-moted aortic plaque formation and increased plaque instability in atherosclerotic mice.Conclusions PCSK9 can in-duce VSMC phenotypic transformation from the contractile to synthetic phenotype,exacerbating the atherosclerotic lesions in mice.This mechanism may involve the signaling crosstalk among NF-κB,KLF4,and MYOCD.
陈佳琳;唐志晗;刘录山;向琼;彭娟
南华大学心血管疾病研究所 动脉硬化学湖南省重点实验室 湖南省动脉硬化性疾病国际科技创新合作基地,湖南省 衡阳市 421001南华大学心血管疾病研究所 动脉硬化学湖南省重点实验室 湖南省动脉硬化性疾病国际科技创新合作基地,湖南省 衡阳市 421001南华大学心血管疾病研究所 动脉硬化学湖南省重点实验室 湖南省动脉硬化性疾病国际科技创新合作基地,湖南省 衡阳市 421001南华大学心血管疾病研究所 动脉硬化学湖南省重点实验室 湖南省动脉硬化性疾病国际科技创新合作基地,湖南省 衡阳市 421001南华大学心血管疾病研究所 动脉硬化学湖南省重点实验室 湖南省动脉硬化性疾病国际科技创新合作基地,湖南省 衡阳市 421001
医药卫生
前蛋白转化酶枯草溶菌素9动脉粥样硬化血管平滑肌细胞表型转换
proprotein convertase subtilisin/kexin type 9atherosclerosisvascular smooth muscle cellsphenotypic transformation
《中国动脉硬化杂志》 2026 (4)
287-296,10
湖南省自然科学基金项目(2022JJ30510)湖南省教育厅科研项目(20C1612)
评论